Effects of gastroesophageal reflux disease treatment with proton pump inhibitors on the risk of acute exacerbation and pneumonia in patients with COPD

BACKGROUND: Gastroesophageal reflux disease (GERD) has been suggested as a risk factor for acute exacerbation of chronic obstructive pulmonary disease (COPD). However, it remains undetermined whether proton pump inhibitor (PPI) treatment reduces the risk of exacerbation or affects the risk of pneumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jieun, Lee, Rugyeom, Lee, Sei Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008570/
https://www.ncbi.nlm.nih.gov/pubmed/36906585
http://dx.doi.org/10.1186/s12931-023-02345-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008570/
https://www.ncbi.nlm.nih.gov/pubmed/36906585
http://dx.doi.org/10.1186/s12931-023-02345-1

Ejemplares similares